Patents for C07K 19 - Hybrid peptides (29,428) |
---|
04/16/2014 | CN103732628A Multivalent heteromultimer scaffold design and constructs |
04/16/2014 | CN103732534A Porous structure and method for producing the same |
04/16/2014 | CN103728458A Applications of rabbit encephalitozoon cuniculi spore wall protein SWP1 to preparation of reagent for diagnosing or detecting rabbit encephalitozoon cuniculi infection |
04/16/2014 | CN103724435A Antibacterial recombinant polypeptide and expression vector thereof |
04/16/2014 | CN103724413A B cell epitope 8A1 of trichina paramyosin and application thereof |
04/16/2014 | CN102532284B A mutated immunoglobulin-binding protein |
04/16/2014 | CN102382194B Autophagy concatenated fluorescent probe mTagRFP-mWasabi-LC3 and application thereof |
04/16/2014 | CN101517077B Multi-gene expression vehicle |
04/15/2014 | US8697648 Protein agent for diabetes treatment and β cell imaging |
04/15/2014 | US8697372 Method for determining the binding of a given compound to a membrane receptor |
04/15/2014 | US8697047 Stable immunogenic product comprising antigenic heterocomplexes |
04/15/2014 | CA2600749C Dimeric or multimeric microproteins |
04/15/2014 | CA2474457C Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state |
04/15/2014 | CA2436208C A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
04/10/2014 | WO2014055663A1 Specific delivery of toxins conjugated wtih antibodies to activated matriptase |
04/10/2014 | WO2014055657A1 Use of a trans-signaling approach in chimeric antigen receptors |
04/10/2014 | WO2013160335A3 Antigens and antigen combinations |
04/10/2014 | US20140099307 New Dendritic Cell Co-Stimulatory Molecules |
04/09/2014 | EP2716661A1 Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof |
04/09/2014 | EP2716660A1 Cell-penetrating fusion protein for regenerating or proliferating stem cell |
04/09/2014 | EP2714738A2 Multivalent and monovalent multispecific complexes and their uses |
04/09/2014 | CN103717615A Pcsk9-binding polypeptides and methods of use |
04/09/2014 | CN103709253A Method for preparing GLP-1 (Glucose-Like Peptide) and analogue thereof by biological synthesis |
04/09/2014 | CN103087154B Polypeptide for preparing monoclonal antibody for detecting acetylcholin esterase and application of polypeptide |
04/09/2014 | CN102964450B OGP-AcAP2 (Osteogenic Growth Peptide) fusion protein for treating osteoporosis and thrombus and nucleic acid for coding fusion protein |
04/09/2014 | CN102827289B Porcine circovirus type 2 Cap protein and thymosin alpha1 fusion protein and application |
04/09/2014 | CN102382190B Method for separating and removing oligomer in TNFR-Fc fusion protein |
04/09/2014 | CN102367277B Polymer conjugates of mutated neublastin |
04/09/2014 | CN102206281B Fusion protein TETPH, expression vector and construction method thereof |
04/09/2014 | CN102046657B Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof |
04/08/2014 | CA2534520C Oligopeptide ligation methods comprising an activated ester moiety or an aldehyde or ketone moiety |
04/03/2014 | WO2014052611A1 Generation of new pancreatic beta cells |
04/03/2014 | WO2014051567A1 Chimeric neuregulins and method of making and use thereof |
04/03/2014 | WO2014051022A1 Fgfr3 fusion gene and pharmaceutical drug targeting same |
04/03/2014 | WO2014048977A1 Albumin binding polzpeptide |
04/03/2014 | WO2014047741A1 Peptide directed protein knockdown |
04/03/2014 | WO2014025199A3 Staphylococcal enterotoxin-derived superantigen mutant, fusion protein in which target-specific polypeptides are connected to the mutant and use thereof |
04/03/2014 | WO2014025198A3 Lfa3 mutant, fusion protein in which target-specific polypeptides are connected to the mutant or lfa3 cd2 binding region, and use thereof |
04/03/2014 | WO2013191591A4 Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae |
04/03/2014 | US20140093956 Modified Human Thymic Stromal Lymphopoietin |
04/02/2014 | CN103695508A Fermentation and purification technologies of staphylococcus aureus HI recombinant protein |
04/02/2014 | CN103695468A Method for expressing EGF-TCSKDEL fusion protein by bombyx mori baculovirus Bac-to-Bac system |
04/02/2014 | CN103694358A Locus specificity biotin labeled recombinant IgG (Intravenous Gamma Globulin) affine peptide and application thereof in IgG antibody three-dimensional oriented fixation |
04/02/2014 | CN103694357A Preparation and application of novel soluble fusion protein DT390-triTMTP1 |
04/02/2014 | CN103184230B Fusion protein gene TAT-sVP7 and application thereof |
04/02/2014 | CN102516396B Induced reversible immortalized anterior odontoblast system and establishment method thereof |
04/01/2014 | US8685893 Phage display |
04/01/2014 | US8685384 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex |
04/01/2014 | US8685372 Peptides and aptamers for targeting of neuron or nerves |
04/01/2014 | CA2687141C Compositions and methods for producing bioactive fusion proteins |
04/01/2014 | CA2531231C Uranium-chelating peptides and uses thereof |
04/01/2014 | CA2488682C Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
03/27/2014 | WO2014047024A1 Iap antagonists |
03/27/2014 | WO2014046732A1 Cyclotide-based cxcr4 antagonists with anti-hiv activity |
03/27/2014 | WO2014046731A1 Preparation of cyclotides |
03/27/2014 | WO2014045621A1 Pneumococcal vaccine containing pneumococcal surface protein a |
03/27/2014 | WO2014045022A2 Agents and methods |
03/27/2014 | US20140088009 Chimeric neuregulins and method of making and use thereof |
03/27/2014 | US20140087422 Nucleic acids related to fusion proteins |
03/26/2014 | EP2711377A1 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof |
03/26/2014 | EP2711376A1 Fgfr-fc fusion protein and use thereof |
03/26/2014 | EP2711375A1 Human Antigen Binding Proteins that bind Beta-Klotho, FGF Receptors and complexes thereof |
03/26/2014 | CN103687880A Amphipathic peptide-lipase conjugate having advanced lipase activity and use thereof |
03/26/2014 | CN103665170A Peptide therapeutic conjugates and uses thereof |
03/26/2014 | CN103665169A Three-function peptide-modified gene carrier as well as preparation method and application thereof |
03/26/2014 | CN103665168A Anti-cd14 antibody-fused protein |
03/26/2014 | CN103665167A Preparation and application of fused polypeptide of calcitonin gene-related peptide and salmon calcitonin |
03/26/2014 | CN103665166A Dog fusion interferon |
03/26/2014 | CN103665133A Alpha-conotoxin peptide LvIA/LvD21, and pharmaceutical composition and use thereof |
03/26/2014 | CN103665130A Alpha-conotoxin peptide TxIC/Txd1 and medicinal composition and application thereof |
03/26/2014 | CN103665113A Human A beta 42 antigenic determinant polypeptide, human A beta 42 antigen, human A beta 42 antibody, application and kit |
03/26/2014 | CN103169986B Mosaic type DNA (Deoxyribonucleic Acid) vaccine pVAXI-Hsp 70/CD 80 for preventing and immunologically treating tuberculosis |
03/26/2014 | CN103130898B TAT-LBD-PEP fusion protein and application of TAT-LBD-PEP fusion protein in treatment of central nervous system lesion |
03/26/2014 | CN102586323B Method for constructing, expressing and purifying targeted immune fusion protein |
03/26/2014 | CN102382195B Insect antimicrobial peptide Drosomycin fusion protein and application thereof in plant disease resistance |
03/25/2014 | US8680244 Method for the production of antibodies that bind to multiple membrane spanning proteins |
03/25/2014 | US8679785 Knobs and holes heteromeric polypeptides |
03/25/2014 | CA2668045C Peptide chimeric molecules having antiviral properties against viruses of the flaviviridae family |
03/25/2014 | CA2607142C Personal care compositions and methods for their use |
03/25/2014 | CA2435000C Oligomeric complexes of chimeric proteins with enhanced immunogenic potential |
03/25/2014 | CA2434672C Sfrp and peptide motifs that interact with sfrp and methods of their use |
03/20/2014 | WO2014043561A1 Reversible chemoenzymatic labeling of native and fusion carrier protein motifs |
03/20/2014 | WO2014043403A1 Amatoxin derivatives and cell-permeable conjugates thereof as inhibitors of rna polymerase |
03/20/2014 | WO2014042209A1 Peptides that bind to epithelial cell adhesion molecule |
03/20/2014 | WO2014040129A1 Protease-based biosensor |
03/19/2014 | EP2707482A1 Whole cell biocatalyst comprising a prenyltransferase |
03/19/2014 | EP2707395A2 Novel fusion partners for the purpose of crystallizing g-protein coupled receptors |
03/19/2014 | EP2707394A2 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof |
03/19/2014 | EP2707393A1 Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a |
03/19/2014 | CN103649127A Compositions, uses and methods for treatment of metabolic disorders and diseases |
03/19/2014 | CN103649126A Compositions for regulating iron homeostasis and methods of using same |
03/19/2014 | CN103649114A Novel immunoconjugates |
03/19/2014 | CN103649112A Modified laminin and use thereof |
03/19/2014 | CN103641921A Multi-epitope fusion antigen and kit for detecting porcine reproductive and respiratory syndrome virus serum antibody |
03/19/2014 | CN103641920A Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (PRRSV) and uses thereof |
03/19/2014 | CN103641919A Immunoglobulin fusion proteins |
03/19/2014 | CN103641918A OX40/TRAIL fusion proteins |
03/19/2014 | CN103641905A Interferon alpha1b mutant and fusion protein containing interferon alpha1b and human serum albumin |
03/19/2014 | CN103641896A Use of gelatin-like unit |
03/19/2014 | CN102977215B Caspase-1 inhibitor targeting liver and application thereof |